We are live on ! Find out more
SCM

Silverarc Capital Management Portfolio holdings

AUM $849M
1-Year Est. Return 470.8%
This Fund
S&P 500
This Quarter Est. Return
+18.81%
1 Year Est. Return
+470.8%
3 Year Est. Return
+3,352.06%
5 Year Est. Return
+7,957.7%
10 Year Est. Return
–
AUM
$447M
AUM Growth
+$3.47M
Cap. Flow
+$20M
Cap. Flow %
4.47%
Top 10 Hldgs %
48.85%
Holding
81
New
11
Increased
34
Reduced
11
Closed
21

Top Buys

1
PLRX icon
Pliant Therapeutics
PLRX
+$18M
2
SNDX icon
Syndax Pharmaceuticals
SNDX
+$14.6M
3
VRNA
Verona Pharma
VRNA
+$6.28M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$6.17M
5
ASND icon
Ascendis Pharma A/S
ASND
+$6.11M

Top Sells

1
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
+$14M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$9.84M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$6.6M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$6.4M
5
ADCT icon
ADC Therapeutics
ADCT
+$5.65M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUVL icon
1
Nuvalent
NUVL
$9.81B
$31.3M 7%
400,014
+28,573
+8% +$2.67M
MRUS
2
DELISTED
Merus
MRUS
$28.6M 6.4%
680,845
+45,406
+7% +$2.18M
INSM icon
3
Insmed
INSM
$23.5B
$25.7M 5.75%
372,230
+24,535
+7% +$1.77M
VRNA
4
DELISTED
Verona Pharma
VRNA
$24M 5.36%
516,014
+167,148
+48% +$6.28M
AKRO
5
DELISTED
Akero Therapeutics
AKRO
$20.6M 4.6%
739,563
+99,723
+16% +$3.02M
VCYT icon
6
Veracyte
VCYT
$4.67B
$19.9M 4.46%
503,281
+32,716
+7% +$1.24M
ERAS icon
7
Erasca
ERAS
$6.23B
$18.9M 4.23%
7,543,901
+597,413
+9% +$1.64M
PLRX icon
8
Pliant Therapeutics
PLRX
$68.7M
$17.3M 3.87%
+1,315,601
New +$18M
SNDX icon
9
Syndax Pharmaceuticals
SNDX
$2.12B
$16.3M 3.64%
1,230,400
+851,654
+225% +$14.6M
RNAM
10
DELISTED
Avidity Biosciences
RNAM
$15.8M 3.54%
543,651
+68,096
+14% +$2.85M
RYTM icon
11
Rhythm Pharmaceuticals
RYTM
$7.42B
$15.3M 3.43%
273,896
+18,318
+7% +$1.01M
ITCI
12
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$15M 3.34%
179,085
+11,975
+7% +$984K
URGN icon
13
UroGen Pharma
URGN
$1.88B
$11.9M 2.67%
1,120,473
+219,344
+24% +$2.63M
CNTA
14
DELISTED
Centessa Pharmaceuticals
CNTA
$10M 2.24%
598,952
-145,640
-20% -$2.41M
KOD icon
15
Kodiak Sciences
KOD
$2.61B
$9.95M 2.22%
1,000,000
+500,000
+100% +$2.87M
PSTX
16
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$9.72M 2.17%
1,012,307
-2,675,241
-73% -$14M
ORIC icon
17
Oric Pharmaceuticals
ORIC
$1.11B
$9.51M 2.13%
1,178,300
+78,810
+7% +$723K
TELA icon
18
TELA Bio
TELA
$37.1M
$9.26M 2.07%
3,065,649
+1,940,721
+173% +$5.46M
SRRK icon
19
Scholar Rock
SRRK
$6.44B
$7.92M 1.77%
+183,243
New +$5.97M
WVE icon
20
Wave Life Sciences
WVE
$1.15B
$7.53M 1.68%
608,897
-18,655
-3% -$249K
COGT icon
21
Cogent Biosciences
COGT
$6.57B
$7.18M 1.61%
921,137
-300,225
-25% -$2.99M
ASND icon
22
Ascendis Pharma A/S
ASND
$17.4B
$7.09M 1.59%
51,491
+46,491
+930% +$6.11M
IRON icon
23
Disc Medicine
IRON
$2.86B
$7M 1.56%
110,381
+6,519
+6% +$377K
CLDX icon
24
Celldex Therapeutics
CLDX
$2.99B
$6.69M 1.49%
264,560
+119,560
+82% +$3.25M
ELUT icon
25
Elutia
ELUT
$40.7M
$6.67M 1.49%
1,782,271
+136,463
+8% +$529K
1
2 3 4

Similar funds

BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
EFG
Embree Financial Group Chicago, Illinois $849M AUM 19.63% 1-Year Est. Return
LA
Legacy Advisors Plymouth Meeting, Pennsylvania $848M AUM 21.32% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
CFP
Catalyst Financial Partners Boston, Massachusetts $847M AUM 29.19% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $846M AUM 32.1% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return